-
Je něco špatně v tomto záznamu ?
Strong Antimicrobial and Healing Effects of Beta-Acids from Hops in Methicillin-Resistant Staphylococcus aureus-Infected External Wounds In Vivo
R. Sleha, V. Radochova, J. Malis, A. Mikyska, M. Houska, K. Krofta, K. Bogdanova, S. Janovska, J. Pejchal, M. Kolar, P. Cermak, P. Bostik
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
NV- 17-31765A
Czech Health Research Council of Czech Republic
NV17-31765A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
- Publikační typ
- časopisecké články MeSH
Staphylococcus (S.) aureus is an important causative agent of wound infections with increasing incidence in the past decades. Specifically, the emergence of methicillin-resistant S. aureus (MRSA) causes serious problems, especially in nosocomial infections. Therefore, there is an urgent need to develop of alternative or supportive antimicrobial therapeutic modalities to meet these challenges. Purified compounds from hops have previously shown promising antimicrobial effects against MRSA isolates in vitro. In this study, purified beta-acids from hops were tested for their potential antimicrobial and healing properties using a porcine model of wounds infected by MRSA. The results show highly significant antimicrobial effects of the active substance in both the powder and Ambiderman-based application forms compared to both no-treatment control and treatment with Framycoin. Moreover, the macroscopic evaluation of the wounds during the treatment using the standardized Wound Healing Continuum indicated positive effects of the beta-acids on the overall wound healing. This is further supported by the microscopic data, which showed a clear improvement of the inflammatory parameters in the wounds treated by beta-acids. Thus, using the porcine model, we demonstrate significant therapeutic effects of hops compounds in the management of wounds infected by MRSA. Beta-acids from hops, therefore, represent a suitable candidate for the treatment of non-responsive nosocomial tissue infections by MRSA.
Food Research Institute 110 00 Prague Czech Republic
Hop Research Institute 438 01 Zatec Czech Republic
Research Institute of Brewing and Malting 110 00 Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024577
- 003
- CZ-PrNML
- 005
- 20211013133854.0
- 007
- ta
- 008
- 211006s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/antibiotics10060708 $2 doi
- 035 __
- $a (PubMed)34204644
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Sleha, Radek $u Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Kralove, Czech Republic
- 245 10
- $a Strong Antimicrobial and Healing Effects of Beta-Acids from Hops in Methicillin-Resistant Staphylococcus aureus-Infected External Wounds In Vivo / $c R. Sleha, V. Radochova, J. Malis, A. Mikyska, M. Houska, K. Krofta, K. Bogdanova, S. Janovska, J. Pejchal, M. Kolar, P. Cermak, P. Bostik
- 520 9_
- $a Staphylococcus (S.) aureus is an important causative agent of wound infections with increasing incidence in the past decades. Specifically, the emergence of methicillin-resistant S. aureus (MRSA) causes serious problems, especially in nosocomial infections. Therefore, there is an urgent need to develop of alternative or supportive antimicrobial therapeutic modalities to meet these challenges. Purified compounds from hops have previously shown promising antimicrobial effects against MRSA isolates in vitro. In this study, purified beta-acids from hops were tested for their potential antimicrobial and healing properties using a porcine model of wounds infected by MRSA. The results show highly significant antimicrobial effects of the active substance in both the powder and Ambiderman-based application forms compared to both no-treatment control and treatment with Framycoin. Moreover, the macroscopic evaluation of the wounds during the treatment using the standardized Wound Healing Continuum indicated positive effects of the beta-acids on the overall wound healing. This is further supported by the microscopic data, which showed a clear improvement of the inflammatory parameters in the wounds treated by beta-acids. Thus, using the porcine model, we demonstrate significant therapeutic effects of hops compounds in the management of wounds infected by MRSA. Beta-acids from hops, therefore, represent a suitable candidate for the treatment of non-responsive nosocomial tissue infections by MRSA.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Radochova, Vera $u Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Kralove, Czech Republic
- 700 1_
- $a Malis, Jiri $u Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Kralove, Czech Republic $u Thomayer Hospital, 110 00 Prague, Czech Republic
- 700 1_
- $a Mikyska, Alexander $u Research Institute of Brewing and Malting, 110 00 Prague, Czech Republic
- 700 1_
- $a Houska, Milan $u Food Research Institute, 110 00 Prague, Czech Republic
- 700 1_
- $a Krofta, Karel $u Hop Research Institute, 438 01 Zatec, Czech Republic
- 700 1_
- $a Bogdanova, Katerina $u Department of Microbiology, Faculty of Medicine and Dentistry, University Hospital, Palacky University, 771 47 Olomouc, Czech Republic
- 700 1_
- $a Janovska, Sylva $u Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Kralove, Czech Republic
- 700 1_
- $a Pejchal, Jaroslav $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Kralove, Czech Republic
- 700 1_
- $a Kolar, Milan $u Department of Microbiology, Faculty of Medicine and Dentistry, University Hospital, Palacky University, 771 47 Olomouc, Czech Republic
- 700 1_
- $a Cermak, Pavel $u Thomayer Hospital, 110 00 Prague, Czech Republic
- 700 1_
- $a Bostik, Pavel $u Department of Epidemiology, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Kralove, Czech Republic $u Institute of Clinical Microbiology, Faculty of Medicine in Hradec Kralove, Charles University and University Hospital, 500 05 Hradec Kralove, Czech Republic
- 773 0_
- $w MED00195446 $t Antibiotics (Basel, Switzerland) $x 2079-6382 $g Roč. 10, č. 6 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34204644 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20211006 $b ABA008
- 991 __
- $a 20211013133851 $b ABA008
- 999 __
- $a ind $b bmc $g 1708380 $s 1145074
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 10 $c 6 $e 20210612 $i 2079-6382 $m Antibiotics (Basel) $n Antibiotics $x MED00195446
- GRA __
- $a NV- 17-31765A $p Czech Health Research Council of Czech Republic
- GRA __
- $a NV17-31765A $p MZ0
- LZP __
- $a Pubmed-20211006